An updated mini-review on the impact of lithium therapy on the parathyroid glands function and structure

Bipolar disorders are among the most significant neuropsychiatric conditions, affecting many people annually worldwide. Despite being accepted as one of the most effective treatments for this illness, lithium, like any other medicine, is associated with a number of adverse effects. Lithium’s adverse effects are divided into acute and chronic categories. The acute effects include renal, thyroid, and parathyroid dysfunction and hypercalcemia, while the chronic effects involve parathyroid hyperplasia and adenoma, among others. This paper will discuss the physiopathology, prevalence, symptoms, diagnosis, and treatment of lithium’s adverse effects.

[1]  M. Haissaguerre,et al.  WHAT AN ENDOCRINOLOGIST SHOULD KNOW FOR PATIENTS RECEIVING LITHIUM THERAPY. , 2022, Annales d'endocrinologie.

[2]  L. Melton,et al.  Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades. , 2016, The Journal of clinical endocrinology and metabolism.

[3]  J. Geddes,et al.  Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data , 2015, The Lancet.

[4]  U. Albert,et al.  Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study , 2015, Neuropsychiatric disease and treatment.

[5]  G. Maina,et al.  Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura Lithium treatment and potential long-term side effects: a systematic review of the literature , 2014 .

[6]  R. Eastell,et al.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. , 2014, The Journal of clinical endocrinology and metabolism.

[7]  Erika F. H. Saunders,et al.  Lithium Therapy and Hyperparathyroidism: An Evidence-Based Assessment , 2009, World Journal of Surgery.

[8]  H. Freund,et al.  Lithium-associated hyperparathyroidism: report of four cases and review of the literature. , 2008, European journal of endocrinology.

[9]  R. Baldessarini,et al.  Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. , 2007, Psychiatric services.

[10]  J. Sloand,et al.  Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  S. Van Uum,et al.  Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  S. Awad,et al.  Parathyroid Adenomas versus Four-gland Hyperplasia as the Cause of Primary Hyperparathyroidism in Patients with Prolonged Lithium Therapy , 2003, World Journal of Surgery.

[13]  R. Lenox,et al.  Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks , 2003, Molecular Psychiatry.

[14]  A. Stoll,et al.  Alterations in parathyroid dynamics in lithium-treated subjects. , 1997, The Journal of clinical endocrinology and metabolism.

[15]  C. McHenry,et al.  Lithium therapy and disorders of the parathyroid glands. , 1996, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.